Status:
WITHDRAWN
Randomized Controlled Pilot Trial of DASH Feeding in Older Low Socioeconomic Adults Without Heart Failure
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Heart Failure
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
60-74 years
Phase:
NA
Brief Summary
This is a study of the DASH diet (Dietary Approaches to Stop Hypertension) in the exploration of effective strategies for Heart failure (HF) with preserved ejection fraction (HFPEF) prevention.
Detailed Description
This is a feasibility pilot, randomized clinical trial (RCT), DASH diet feeding trial in 40 older adults. It will also elicit trends in left ventricular remodeling and pathophysiology. This trial inve...
Eligibility Criteria
Inclusion
- Participants will have an education level of less than college as a surrogate marker of LSES.
Exclusion
- Participants should not have a diagnosis of heart failure or loop diuretics on their medication list in the EHR or symptoms of dyspnea, edema (assessed via questionnaire)
- poorly controlled diabetes mellitus ( HBA 1c \>9%)
- or uncontrolled hypertension ( SBP\>180, DBP\>110)
- cardiovascular event (MI, stroke, HF, angina, atrial fibrillation) within the previous six months
- chronic diseases that might interfere with participation (dementia, schizophrenia, dialysis or transplant recipient patients)
- body-mass index (the weight in kilograms divided by the square of the height in meters) of more than 35
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04113291
Start Date
December 1 2021
End Date
June 1 2022
Last Update
October 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157